Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Total Current Liabilities (2020 - 2025)

BioAtla (BCAB) has 6 years of Total Current Liabilities data on record, last reported at $18.0 million in Q3 2025.

  • For Q3 2025, Total Current Liabilities fell 7.59% year-over-year to $18.0 million; the TTM value through Sep 2025 reached $18.0 million, down 7.59%, while the annual FY2024 figure was $14.5 million, 48.7% down from the prior year.
  • Total Current Liabilities reached $18.0 million in Q3 2025 per BCAB's latest filing, up from $16.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $45.2 million in Q3 2021 and bottomed at $14.5 million in Q4 2024.
  • Average Total Current Liabilities over 5 years is $24.6 million, with a median of $23.1 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: soared 52.78% in 2023, then crashed 48.7% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $19.8 million in 2021, then grew by 16.75% to $23.1 million in 2022, then rose by 22.54% to $28.3 million in 2023, then plummeted by 48.7% to $14.5 million in 2024, then increased by 23.69% to $18.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $18.0 million in Q3 2025, $16.6 million in Q2 2025, and $16.0 million in Q1 2025.